Package(a):
SINGLE DOSE VIAL: 1 x 3.75 mg/vial: 1 x monthly. Dosage(a):
Both I.M. or S.C. with diluent and syringe (with needles and alcohol wipe). Prescribing Restrictions:
Package(b):
SINGLE DOSE VIAL: 1 x 11.25 mg/vial: 1 x every 3 months. Dosage(b):
Both I.M. or S.C. with diluent and syringe (with needles and alcohol wipe). Prescribing Restrictions:
Package(c):
PREFILLED DUAL CHAMBER SYRINGE (PDCS): 1 x 3.75 mg. Dosage(c):
Both I.M. or S.C. Prescribing Restrictions: None
Package(d):
PREFILLED DUAL CHAMBER SYRINGE (PDCS): 1x 11.25 mg. Dosage(d):
Both I.M. or S.C. Prescribing Restrictions: None
Indications:
Prostatic carcinoma, endometriosis, uterine fibroids (for up to 6 months).
Treatment of breast cancer in pre- and peri-menopausal women in whom hormone therapy is specified. Contra-Indications:
See prescribing information for full details. Special Precautions:
See prescribing information for full details. Side Effects:
See prescribing information for full details. Drug Interactions:
See prescribing information for full details.